Rxivist logo

Accurate detection of circulating tumor DNA using nanopore consensus sequencing

By Alessio Marcozzi, Myrthe Jager, Martin Elferink, Roy Straver, Joost H van Ginkel, Boris Peltenburg, Li-Ting Chen, Ivo Renkens, Joyce van Kuik, Chris Terhaard, Remco de Bree, Lot A Devriese, Stefan M Willems, Wigard P. Kloosterman, Jeroen de Ridder

Posted 15 Jul 2020
bioRxiv DOI: 10.1101/2020.07.14.202010

Levels of circulating tumor DNA (ctDNA) in liquid biopsies may serve as a sensitive biomarker for real-time, minimally-invasive tumor diagnostics and monitoring. However, detecting ctDNA is challenging, as much fewer than 5% of the cell-free DNA in the blood typically originates from the tumor. To detect lowly abundant ctDNA molecules based on somatic variants, extremely sensitive sequencing methods are required. Here, we describe a new technique, CyclomicsSeq, which is based on Oxford Nanopore sequencing of concatenated copies of a single DNA molecule. Consensus calling of the DNA copies increased the base-calling accuracy ~60x, enabling accurate detection of ​TP53 mutations at frequencies down to 0.02%. We demonstrate that TP53-specific CyclomicsSeq assay can be successfully used to monitor tumor burden during treatment for head-and-neck cancer patients. CyclomicsSeq can be applied to any genomic locus and offers an accurate diagnostic liquid biopsy approach that can be implemented in point-of-care clinical workflows. ### Competing Interest Statement The authors declare the following financial competing interest: A.M., R.S., W.P.K., and J.d.R filed patents and A.M., W.P.K., and J.d.R founded a company (Cyclomics) based on CyclomicsSeq.

Download data

  • Downloaded 757 times
  • Download rankings, all-time:
    • Site-wide: 21,321 out of 103,802
    • In cancer biology: 656 out of 3,707
  • Year to date:
    • Site-wide: 4,400 out of 103,802
  • Since beginning of last month:
    • Site-wide: 1,805 out of 103,802

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)